Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 108
Selected: 0
NCT IDTitle
NCT02852798Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC
NCT02861482Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage
NCT05847959The Relationship Between XinKang-I and Chronic Heart Failure
NCT03085277Bovine Colostrum for Preterm Newborns
NCT04829123The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects
NCT06577792Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NCT06134908PRevention of OsTEoporotiC FracTure 2 Pilot Study
NCT02499718Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease
NCT04940091Epidural Analgesia and Maternal Fever During Labor
NCT07539753Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases
NCT04135872Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke
NCT02663557The Influence of day-to Day BPV on Long-term Adverse Outcomes in Patients Ischemic Stroke
NCT03310931Predictive Significance of TEG on END in Patients With Acute Ischemic Stroke
NCT06802835EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
NCT06379243Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures
NCT03884673Dolutegravir Plus Lamivudine Simplified Therapy
NCT06032819Differentiating Between Brain Hemorrhage and Contrast
NCT07514611Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial
NCT03191773A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
NCT04155515A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients
NCT03913312Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML
NCT07643636Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
NCT05845372Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy
NCT03593447To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients
NCT06843356Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window
NCT07822789Chidamide in HR-AML
NCT05844163Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
NCT03154749DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
NCT07650799AI-assisted Rare Disease Diagnosis
NCT05290545Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
NCT05343325The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
NCT07813390Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure
NCT07353749Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms
NCT03610880To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers
NCT04119726The Study Design of a Mobile Health (mHealth) Technology Associated Improvement of Drug Adherence in Patients With Acute Myocardial Infarction and Protocol for the Randomized, Controlled Trial(RESCIND-3)
NCT04041349Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
NCT03942094Nilotinib for First-line Newly Diagnosed CML-CP Patients
NCT05769712A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity
NCT04990752Effects of Ulinastatin on Inflammatory Response During ECMO Support
NCT03909555Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 Diabetes
NCT03928119reGional Network for Acute Myocardial Infarction
NCT07754734STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation
NCT06151106Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma
NCT06763666CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
NCT03700801Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
NCT03701217Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
NCT07337694Exploring the Clinical Value of an AI-Assisted Patient Self-Assessment App for Bowel Preparation: A Multicenter Study
NCT06836505Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
NCT06810791HVA vs IA/DA or VA in the Treatment of ND HR-AML
NCT07537257VEN+IDAC vs IDAC in AML